IVGN Invitrogen (MM)

Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, will announce its third quarter 2008 earnings on Tuesday, October 21, 2008, after Market close. Following the earnings release, Invitrogen senior management will hold a live webcast at 4:30 p.m. EDT to discuss the financial and business results in more detail. The webcast can be accessed on Invitrogen�s Web site at www.invitrogen.com on the Investor Relations home page. Alternatively, callers may listen to the live conference call by dialing 800.299.0433 (domestic) or 617.801.9712 (international) and use passcode 59590328. A replay of the webcast will be available on the Company�s website through Tuesday, November 11, 2008. About Invitrogen Invitrogen Corporation (NASDAQ:IVGN) provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen�s own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, stem cells, cell therapy and cell biology � placing Invitrogen�s products in nearly every major laboratory in the world. Founded in 1987, Invitrogen is headquartered in Carlsbad, CA, and conducts business in more than 70 countries around the world. The company employs approximately 4,700 scientists and other professionals and had revenues of approximately $1.3 billion in 2007. For more information, visit www.Invitrogen.com.